Angiogenesis in myelodysplastic syndromes

British Journal of Cancer

Volumn 81, Issue 8, 1999, Pages 1398-1401

  Pruneri, G ^a   Bertolini, F ^a,c   Soligo, D ^a   Carboni, N ^a   Cortelezzi, A ^b   Ferrucci, P F ^a   Buffa, R ^a   Lambertenghi Deliliers, G ^a   Pezzella, F ^d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c IRCCS   (Italy)

^d NONE

Author keywords

Angiogenesis; Leukaemia; Myelodysplasia; VEGF

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BIOPSY; BLAST CELL; BONE MARROW; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFECTION; LEUKEMIA; MAJOR CLINICAL STUDY; MEGAKARYOCYTE; MICROVASCULATURE; MYELODYSPLASIA; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 0032753447     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6693515     Document Type: Article

References (23)

1. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C and Selhy PJ (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets; significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964
2. Bohem T, Folkman J, Browder T and O'Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390. 404-407
3. Fernandez-Acenero MJ, Gonzalez JF, Galindo Gallego M and Aragoncillo Ballestreros P (1998) Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol 16: 1684-1688
4. Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocrine Rev 18: 4-25
5. Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M and Hossfeld DK (1997) Vascular endothelial growth factor, a possible paracrine factor in human acute myeloid leukemia. Blood 89: 1870-1875
6. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
7. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med 1: 27-31
8. Foss HD, Araujo I, Demel G, Klotzback H, Hummel M and Stein H (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 183: 44-50
9. Fukumura D, Xavier R, Sugiura T, Chen Y, Park E, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed B (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725
10. Gimbrone MA, Leapman SB, Cotran RS and Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization, J Exp Med 136: 261-276
11. Graham C, Rivers J, Kerbel R, Stankiewicz K and White W (1994) Extent of neovascularization as a prognostic Indicator in thin (<0.76 mm) melanomas. Am J Pathol 145: 510-514
12. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G and Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088
13. Harris AL (1997) Antiangiogenesis for cancer therapy. Lancet 349: 13-15
14. Lewis CE, Leek R, Harris A and McGee JO (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leuk Biol 57: 747-751
15. Linderholm B, Tavelin B, Grankvist K and Henriksson R (1998) Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 16: 3121-3128
16. Mohle R, Green D, Moore MA, Nachman RL and Rafii S (1997) Constitutive production and thrombin induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94: 663-668
17. Nguyen M, Watanabe H, Budson AE, Richie JP. Hayes DF and Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-361
18. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E and Folkman J (1997) Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150: 815-821
19. Salven P, Tecrenhovi L and Joensuu H (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non Hodgkin's lymphoma. Blood 90: 3167-3172
20. Solanilla A, Grosset C, Lemercier C, Dupouy M, Mahon FX, Schweitzer K, Reiffers J, Weksler B and Ripoche J (1998) Expression of Flt3-ligand by the endothelial cell. Regulation by IL-1α, glucocorticoids, IFN-α, IFN-α, MIP-1α and TGFβ. Key role in the proliferation of primitive hematopoietic progenitors. Blood 92: 580a (abstract)
21. Vacca A, Ribatti D, Roneali L, Ranieri G, Serio G, Silvestris F and Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87: 503-508
22. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation with invasive breast carcinoma. N Engl J Med 324: 1-8
23. Yamaguchi H, Ishii E, Saito S, Tashiro K, Fujita I, Yoshiodomi S, Ohtubo M, Akazawa K and Miyazaki S (1996) Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 94: 606-611